Initial characterization of human platelet mepacrine-labelled granules isolated using a short metrizamide gradient.
A method for the purification of human platelet mepacrine-labelled granules is described. Characterization of these isolated granules allowed them to be identified as the serotonin storage organelles or dense bodies. Each step of the purification procedure has been controlled in order to obtain a minimum of leakage of the granule content during initial isolation of the platelets from the blood, the platelet washing procedures, and platelet lysis and the subcellular separation. A key step in the procedure was the centrifugation of the labelled granules across a short, discontinuous metrizamide gradient. The pellet of isolated mepacrine-fluorescent granules consisted almost entirely of granules with the typical appearance of dense bodies, as shown by electron microscopy, and was relatively free from membranes and other granule populations as evaluated by the presence of the different markers (tritiated lectin, beta-glucuronidase, monoamine oxidase, platelet factor 4). The method is simple, reproducible and allows the highest enrichment in dense bodies obtained hitherto with human platelets: x 177 in calcium and x 115 in [14C]serotonin after fractionation of [14C]serotonin-labelled whole platelets. Functional studies performed with the isolated granules showed that they rapidly accumulated [14C]serotonin.
D000255:Adenosine Triphosphate / Q000097:blood; D001792:Blood Platelets / Q000378:metabolism / Q000648:ultrastructure*; D002118:Calcium / Q000097:blood; D002458:Cell Fractionation / Q000379:methods; D002499:Centrifugation, Density Gradient; D003594:Cytoplasmic Granules / Q000648:ultrastructure*; D006801:Humans; D008793:Metrizamide; D008854:Microscopy, Electron; D011796:Quinacrine / Q000378:metabolism*; D012701:Serotonin / Q000097:blood
D012701:Serotonin; D000255:Adenosine Triphosphate; D011796:Quinacrine; D008793:Metrizamide; D002118:Calcium